Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer

Walter M. Stadler*, Timothy Kuzel, Bruce Roth, Derek Raghavan, F. Andrew Dorr

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

316 Scopus citations

Fingerprint

Dive into the research topics of 'Phase II study of single-agent gemcitabine in previously untreated patients with metastatic urothelial cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences